KRTX - Karuna Therapeutics GAAP EPS of -$2.22 beats by $0.06 revenue of $5.28M
- Karuna Therapeutics press release ( NASDAQ: KRTX ): Q4 GAAP EPS of -$2.22 beats by $0.06 .
- Revenue of $5.28M (-85.7% Y/Y).
- $1.1 billion in cash is expected to fund operations through the end of 2025
For further details see:
Karuna Therapeutics GAAP EPS of -$2.22 beats by $0.06, revenue of $5.28M